Cedric O'Gorman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Cedric O'Gorman
Cedric O'Gorman has spoken on 1 earnings call across 1 company, most recently for Relmada Therapeutics, Inc. on November 8, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Relmada Therapeutics, Inc. (RLMD)
Source not stated
Current -
Axsome Therapeutics, Inc. (AXSM)
Proxy statement
Start not stated–2021-04-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Relmada Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Sergio Traversa CEO, Board Member
- Charles J. Casamento Chairman, Board Member
- Maged Shenouda CFO
- Paul Kelly COO, Board Member
- Charles Ence Chief Accounting Officer
- Fabiana Fedeli Board Member
- John Glasspool Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.